Some of the extracts evaluated in this study were able to reduce TNF-α release selectively, whereas others inhibited preferably CCL2, pointing out the first group of plants as potential sources of compounds for management of rheumatoid arthritis, whereas the second ones would be more suited for the treatment of cardiovascular diseases like atherosclerosis. The gene discussed is CCL2; the disease is cardiovascular disorder.